AgingFaceAgeNCT07719049
Artificial Intelligence-Based Health Assessment From Face Photographs - Healthy Volunteer Study
An observational study of Aging and Facial Aging, run by Brigham and Women's Hospital at 1 site in United States.
Trial summary
The investigators aim to examine how FaceAge estimates (a measure of biological age based on facial features) change across different time points and identify factors that may influence these changes. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Aging, Facial Aging
- How many people
- 10,000 participants
- Where
- 1 siteUnited States
- Study dates
- 23 Oct 2025to Oct 2027
- How long will I take part?
- 3 Years
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Any healthy individual that has not/has never received care from any MGB affiliated institution.
Who may be able to join
- The protocol enrolls healthy volunteers from the adult (age 18 and above) general population. All races and genders will be included.
Who cannot join
- Any skin condition or recent facial injury that could affect facial appearance.
- Inability to follow study instructions or provide informed consent.
- Taking new or strong medication on the day of image capture could potentially affect appearance or alertness.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Fridolin Haugg, MS contact
United States1 site, 1 recruiting
- Recruiting
Brigham and Women's Hospital
Boston, Massachusetts, 02115
Andrew Warrington, BS, (617) 632-5734, bwhfaceage@mgb.org
Fridolin Haugg, MS, (617) 632-5734, bwhfaceage@mgb.org
About this study
Official title: Artificial Intelligence-Based Phenotyping of Health From Photographs - Healthy Volunteer Study
The investigators aim to examine how FaceAge estimates (a measure of biological age based on facial features) change across different time points and identify factors that may influence these changes. This will help the investigators understand the consistency and reliability of the FaceAge algorithm and allow them to make improvements.
Read the detailed description
Historical background
The concept of biological age, as distinct from chronological age, has gained increasing attention in recent years. Biological age aims to quantify the physiological state of an individual, which can be influenced by genetic factors, lifestyle choices, and environmental exposures1-4. With advancements in artificial intelligence, new tools have emerged to estimate biological age and an individual's health from various imaging biomarkers, including facial features.
One such tool is FaceAge, a deep learning system developed to estimate biological age from a single frontal face photograph5. FaceAge represents a step forward in quantifying biological age and an individual's health status, offering a non-invasive and potentially widely applicable method for assessing an individual's aging process.
Various disease states and overall health conditions can impact a person's physical appearance. Additionally, research has established the existence of various biological rhythms in human physiology. These rhythms regulate numerous physiological functions and can influence an individual's appearance and well-being6. It is important to note that different photo settings, such as lighting conditions, facial expressions, and image quality, may lead to variations in AI algorithm performance, such as FaceAge estimates, highlighting the need for a comprehensive investigation of these factors to ensure the robustness and reliability of the algorithm.
Previous pre-clinical or clinical studies leading up to and supporting the proposed research
The first FaceAge study demonstrated the algorithm's effectiveness in estimating biological age across multiple clinical cohorts5. Trained on a dataset of 58,851 healthy individuals, FaceAge showed that cancer patients, on average, appeared approximately five years older than their chronological age. Moreover, FaceAge estimates were associated with survival outcomes and showed correlations with molecular mechanisms of senescence through gene analysis.
Previous research has established that various factors, including health status, lifestyle, and environmental influences, can affect an individual's appearance7,8. Studies have shown that these factors can lead to variations in physical characteristics that may be captured by facial analysis tools5,9.
The rationale behind the proposed research and potential benefits to patients and society
Despite growing evidence supporting the impact of various factors on human physiology and appearance, there is limited research on how these variations might affect estimated biological age from facial features and the validation of AI algorithms like FaceAge require datasets that tests the biomarkers reproducibility, robustness across different imaging conditions and generalizability.
The proposed study addresses this knowledge gap by collecting photographs from volunteers over time. By compiling a database of numerous photos per person, the investigators will generate a resource to test the reproducibility of AI algorithms developed to generate biomarkers from photographs. Additionally, this dataset will provide a resource to assess whether AI predictions such as FaceAge are consistent across individuals, disease type, and time periods. Furthermore, the investigators can rigorously test the model's reproducibility, generalizability and robustness across diverse real-world scenarios by including photos taken under various conditions and from different time points.
This research could provide valuable insights into the reliability and variability of AI algorithms such as FaceAge estimates contribute to the understanding of how various factors may influence human appearance and perceived age and health. If major variations are observed, it could have important implications for using photographs in medical assessments and research studies utilizing FaceAge or similar algorithms.
Understanding these potential variations could lead to more accurate and standardized use of AI-based assessments of health from photographs including facial age estimation tools in clinical settings, potentially improving their prognostic value and applicability in personalized medicine. Moreover, this research may open new avenues for studying the intersection of various health factors and aging, potentially leading to novel interventions to promote healthy aging and improve overall health outcomes.
- Conditions
- Aging, Facial Aging
- Keywords
- Artificial Intelligence, Aging, Biomarkers of Aging
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Healthy volunteers | Individuals that are not currently/have never received care at any MGB affiliated institutions. |
What is being measured
The primary outcome is the main question the study is designed to answer.
FaceAge estimate(s)
AI-generated FaceAge predictions for each photograph.
Measured: Up to three years from the date of enrollment.
Changes in FaceAge estimates
For those with more than one FaceAge estimate, we will evaluate the consistency of FaceAge estimates between photographs taken at different time intervals.
Measured: Up to three years from the date of enrollment.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Jul 2026
- Study start23 Oct 2025
- Primary completionOct 2027 (estimated)
- Study completionOct 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AgingStudies of the same condition, open and under way.
- More trials run by Brigham and Women's HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 10,000 participants (estimated)
- Target duration
- 3 Years
Sponsor and investigators
- Lead sponsor
- Brigham and Women's Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Raymond Mak, Brigham and Women's Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07719049
- Sponsor's protocol ID
- 2024P002684
- Acronym
- FaceAge
- Status last verified
- May 2026
- First submitted
- 17 Jul 2026
- Last updated
- 17 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 17 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Artificial Intelligence-Based Phenotyping of Health From Photographs - Healthy Volunteer Study
- ClinicalTrials.gov ID
- NCT07719049
- Acronym / sponsor ID
- FaceAge / 2024P002684
- Conditions
- Aging, Facial Aging
- Keywords
- Artificial Intelligence, Aging, Biomarkers of Aging
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 10,000 participants (estimated)
- Lead sponsor
- Brigham and Women's HospitalUniversity, hospital or other
- Study start
- 23 Oct 2025 (actual)
- Primary completion
- Oct 2027 (estimated)
- Study completion
- Oct 2027 (estimated)
- First posted
- 22 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The investigators aim to examine how FaceAge estimates (a measure of biological age based on facial features) change across different time points and identify factors that may influence these changes. This will help the investigators understand the consistency and reliability of the FaceAge algorithm and allow them to make improvements.
Detailed description
Historical background
The concept of biological age, as distinct from chronological age, has gained increasing attention in recent years. Biological age aims to quantify the physiological state of an individual, which can be influenced by genetic factors, lifestyle choices, and environmental exposures1-4. With advancements in artificial intelligence, new tools have emerged to estimate biological age and an individual's health from various imaging biomarkers, including facial features.
One such tool is FaceAge, a deep learning system developed to estimate biological age from a single frontal face photograph5. FaceAge represents a step forward in quantifying biological age and an individual's health status, offering a non-invasive and potentially widely applicable method for assessing an individual's aging process.
Various disease states and overall health conditions can impact a person's physical appearance. Additionally, research has established the existence of various biological rhythms in human physiology. These rhythms regulate numerous physiological functions and can influence an individual's appearance and well-being6. It is important to note that different photo settings, such as lighting conditions, facial expressions, and image quality, may lead to variations in AI algorithm performance, such as FaceAge estimates, highlighting the need for a comprehensive investigation of these factors to ensure the robustness and reliability of the algorithm.
Previous pre-clinical or clinical studies leading up to and supporting the proposed research
The first FaceAge study demonstrated the algorithm's effectiveness in estimating biological age across multiple clinical cohorts5. Trained on a dataset of 58,851 healthy individuals, FaceAge showed that cancer patients, on average, appeared approximately five years older than their chronological age. Moreover, FaceAge estimates were associated with survival outcomes and showed correlations with molecular mechanisms of senescence through gene analysis.
Previous research has established that various factors, including health status, lifestyle, and environmental influences, can affect an individual's appearance7,8. Studies have shown that these factors can lead to variations in physical characteristics that may be captured by facial analysis tools5,9.
The rationale behind the proposed research and potential benefits to patients and society
Despite growing evidence supporting the impact of various factors on human physiology and appearance, there is limited research on how these variations might affect estimated biological age from facial features and the validation of AI algorithms like FaceAge require datasets that tests the biomarkers reproducibility, robustness across different imaging conditions and generalizability.
The proposed study addresses this knowledge gap by collecting photographs from volunteers over time. By compiling a database of numerous photos per person, the investigators will generate a resource to test the reproducibility of AI algorithms developed to generate biomarkers from photographs. Additionally, this dataset will provide a resource to assess whether AI predictions such as FaceAge are consistent across individuals, disease type, and time periods. Furthermore, the investigators can rigorously test the model's reproducibility, generalizability and robustness across diverse real-world scenarios by including photos taken under various conditions and from different time points.
This research could provide valuable insights into the reliability and variability of AI algorithms such as FaceAge estimates contribute to the understanding of how various factors may influence human appearance and perceived age and health. If major variations are observed, it could have important implications for using photographs in medical assessments and research studies utilizing FaceAge or similar algorithms.
Understanding these potential variations could lead to more accurate and standardized use of AI-based assessments of health from photographs including facial age estimation tools in clinical settings, potentially improving their prognostic value and applicability in personalized medicine. Moreover, this research may open new avenues for studying the intersection of various health factors and aging, potentially leading to novel interventions to promote healthy aging and improve overall health outcomes.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 3 Years
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Healthy volunteers | – | –Individuals that are not currently/have never received care at any MGB affiliated institutions. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Any healthy individual that has not/has never received care from any MGB affiliated institution.
Key inclusion criteria (1 listed)
- The protocol enrolls healthy volunteers from the adult (age 18 and above) general population. All races and genders will be included.
Key exclusion criteria (3 listed)
- Any skin condition or recent facial injury that could affect facial appearance.
- Inability to follow study instructions or provide informed consent.
- Taking new or strong medication on the day of image capture could potentially affect appearance or alertness.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
FaceAge estimate(s)
Time frame: Up to three years from the date of enrollment.
AI-generated FaceAge predictions for each photograph.
Changes in FaceAge estimates
Time frame: Up to three years from the date of enrollment.
For those with more than one FaceAge estimate, we will evaluate the consistency of FaceAge estimates between photographs taken at different time intervals.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Aug 2026.
- Link to official research website.Link provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Aging
RecruitingPhase 2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Alzheimer's Disease
Recruiting
Colon-delivered Riboflavin and Gut Microbiota Composition
Microbiome Dysbiosis, Gut Health
RecruitingPhase 2
Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)
Multiple Sclerosis
Not yet recruitingPhase 2
Validation & Intervention Testing for Aging, Longevity and Healthspan
Aging, Functional Decline
RecruitingObservational study
Effects of Obesity on Physical Abilities and Daily Living Activities in Elderly Adults
Obesity, Sarcopenic Obesity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Fridolin Haugg, MS contact
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Aging and Facial Aging, run by Brigham and Women's Hospital at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 17 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Raymond Mak, MD ((617) 632-5734, bwhfaceage@mgb.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
FaceAge estimate(s) (time frame: Up to three years from the date of enrollment.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Aug 2026.